Menu
Publication Date: January 22, 2019
Purchase Price: $0.00
View Report Gallery

JP Morgan 2019 - Conference Review

The 37th annual JP Morgan Healthcare Conference took place in San Francisco, CA from January 7-10, 2019. A list of events and catalysts that were announced or updated at the conference are included in this report, as well as key points from the company presentations, and a summary of the State of the Industry Briefing on cell and gene therapies, which was also held in San Francisco, CA.

Highlights from the company presentations are included for: 

Mega Cap

  • Novartis (NVS)
  • Pfizer (PFE)
  • Merck KGaA (MKGAY)

Large Cap

  • Abbott Labs (ABT)
  • AbbVie (ABBV)
  • Alexion Pharmaceuticals (ALXN)
  • Allergan (AGN)
  • Amgen (AMGN)
  • Astellas (4503:JP)
  • Biogen (BIIB)
  • BioMarin(BMRN)
  • Boston Scientific (BSX)
  • Bristol Myers (BMY)
  • Celgene (CELG)
  • CSL Ltd (CSL:AU)
  • Daiichi Sankyo (4568.T)
  • Dexcom (DXCM)
  • Gilead (GILD)
  • GlaxoSmithKline (GSK)
  • Incyte (INCY)
  • Ipsen SA (IPSEY)
  • Jazz (JAZZ)
  • Medtronic (MDT)
  • Mylan N.V. (MYL)
  • Regeneron (REGN)
  • Sanofi (SNY)
  • Teva Pharmaceuticals (TEVA)
  • Vertex (VRTX)
  • Zimmer Biomet (ZBH)

Mid Cap

  • Acadia Pharmaceuticals (ACAD)
  • Acceleron (XLRN)
  • Alkermes (ALKS)
  • Allogene Therapeutics (ALLO)
  • Alnylam (ALNY)
  • Amarin Corporation (AMRN)
  • Arena Pharmaceuticals (ARNA)
  • argenx (ARGX)
  • Array (ARRY)
  • Ascendis (ASND)
  • bluebird bio (BLUE)
  • Dynavax Technologies (DVAX)
  • Evotec AG (EVT.DE)
  • Galapagos NV (GLPG)
  • Global Blood Therapeutics (GBT)
  • GW Pharmaceuticals (GWPH)
  • Halozyme Therapeutics (HALO)
  • Immunomedics Inc (IMMU)
  • Intercept Pharmaceutical (ICPT)
  • Lee's Pharmaceutical Holdings (0950.HK)
  • Moderna Therapeutics (MRNA)
  • Morphosys AG (MOR)
  • Nektar Therapeutics (NKTR)
  • Neurocrine Biosciences (NBIX)
  • Novocure (NVCR)
  • Sage Therapeutics (SAGE)
  • Santen (SZD.F)
  • Sarepta (SRPT)
  • Seattle Genetics (SGEN)
  • United Therapeutics (UTHR)

Small Cap/Private

  • Acorda Therapeutics (ACOR)
  • Alder Biotherapeutics (ALDR)
  • AMAG Pharmaceuticals (AMAG)
  • Amicus Therapeutics (FOLD)
  • AnaptysBio (ANAB)
  • Coherus Biosciences (CHRS)
  • Five Prime Therapeutics (FPRX)
  • Idera Pharmaceuticals (IDRA)
  • ImmunoGen (IMGN)
  • Insys Therapeutics (INYS)
  • Intra-Cellular Therapies (ITCI)
  • Ironwood Pharmaceuticals (IRWD)
  • Karyopharm (KPTI)
  • Mallinckrodt (MNK)
  • Molecular Partners AG (MOLN.SW)
  • MyoKardia (MYOK)
  • PTC Therapeutics (PTCT)
  • Replimune (REPL)
  • Rubius Therapeutics (RUBY)
  • Sangamo Therapeutics (SGMO)
  • Sienna Biopharmaceuticals (SNNA)
  • Solid Biosciences (SLDB)
  • Supernus Pharmaceuticals (SUPN)
  • TG Therapeutics (TGTX)
  • Tricida (TCDA)
  • Urogen Pharmaceuticals (URGN)
  • Y-mAbs Therapeutics (YMAB)
  • Ziopharm Oncology (ZIOP)

Micro Cap/Private

  • Adverum Biotechnologies (ADVM)
  • Axovant Sciences (AXON)
  • Basilea Pharmaeuticals (BSLN.SW)
  • FLX Bio
  • Kala Pharmaceuticals (KALA)
  • ORIC Pharmaceuticals
  • Springworks

For the full report, please download the PDF version. 

For our disclosures, please read the Biomedtracker Research Standards.

Back to the top Back to the top